• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nature . The coding capacity of SARS-CoV-2

tetano

Editor, Senior Moderator
Nature


. 2020 Sep 9.
doi: 10.1038/s41586-020-2739-1. Online ahead of print.
The coding capacity of SARS-CoV-2


Yaara Finkel[SUP] 1 [/SUP], Orel Mizrahi[SUP] 1 [/SUP], Aharon Nachshon[SUP] 1 [/SUP], Shira Weingarten-Gabbay[SUP] 2 3 [/SUP], David Morgenstern[SUP] 4 [/SUP], Yfat Yahalom-Ronen[SUP] 5 [/SUP], Hadas Tamir[SUP] 5 [/SUP], Hagit Achdout[SUP] 5 [/SUP], Dana Stein[SUP] 6 [/SUP], Ofir Israeli[SUP] 6 [/SUP], Adi Beth-Din[SUP] 6 [/SUP], Sharon Melamed[SUP] 5 [/SUP], Shay Weiss[SUP] 5 [/SUP], Tomer Israely[SUP] 5 [/SUP], Nir Paran[SUP] 5 [/SUP], Michal Schwartz[SUP] 1 [/SUP], Noam Stern-Ginossar[SUP] 7 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing Coronavirus disease 19 (COVID-19) pandemic[SUP]1[/SUP]. In order to understand SARS-CoV-2 pathogenicity and antigenic potential, and to develop therapeutic tools, it is essential to portray the full repertoire of its expressed proteins. The SARS-CoV-2 coding capacity map is currently based on computational predictions and relies on homology to other coronaviruses. Since coronaviruses differ in their protein array, especially in the variety of accessory proteins, it is crucial to characterize the specific collection of SARS-CoV-2 proteins in an unbiased and open-ended manner. Using a suite of ribosome profiling techniques[SUP]2-4[/SUP], we present a high-resolution map of the SARS-CoV-2 coding regions, allowing us to accurately quantify the expression of canonical viral open reading frames (ORFs) and to identify 23 unannotated viral ORFs. These ORFs include upstream ORFs (uORFs) that are likely playing a regulatory role, several in-frame internal ORFs lying within existing ORFs, resulting in N-terminally truncated products, as well as internal out-of-frame ORFs, which generate novel polypeptides. We further show that viral mRNAs are not translated more efficiently than host mRNAs; rather, virus translation dominates host translation due to high levels of viral transcripts. Our work provides a rich resource, which will form the basis of future functional studies.
 
Back
Top Bottom